SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ICN Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Clouseau who wrote (790)3/26/1998 6:33:00 PM
From: Paul Lee  Respond to of 1029
 
Signs of Growth

ICN Pharmaceuticals will be transferred from the S&P SmallCap 600 to the S&P MidCap 400 on March 31

The company will be added to the S&P MidCap 400 Health Care (Drugs-Generic & Other) industry group.



To: Clouseau who wrote (790)3/26/1998 10:01:00 PM
From: Robert Florin  Read Replies (2) | Respond to of 1029
 
Somebody must be taking a position, based on the number of big block trades, and high volume, dontcha think?

That was an astute observation. Looks like they have already been taking the position before the announcement. But I imagine we can anticipate even more.